Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Team devises new way to manufacture RBCs

    Author:
    HT Staff
    Publish date: March 28, 2017

    Researchers say they have generated the first human immortalized adult erythroid line that provides a sustainable supply of erythroid cells. The...

    • Read More

    News

    Protein may prevent transformation from MDS to AML

    Author:
    HT Staff
    Publish date: March 28, 2017

    The protein p300 may prevent the transformation from myelodysplastic syndromes (MDS) to acute myeloid leukemia (AML), according to research...

    • Read More

    News

    Model could advance fight against malaria

    Author:
    HT Staff
    Publish date: March 28, 2017

    A new mathematical model could aid the development of drugs that target malaria parasites’ metabolic processes, according to researchers. The...

    • Read More

    News

    Lower risk of heart attack with VKAs than with DOACs, aspirin

    Author:
    HT Staff
    Publish date: March 27, 2017

    A large, retrospective study suggests patients with atrial fibrillation may have a lower risk of acute myocardial infarction (AMI) if they receive...

    • Read More

    News

    Company again withdraws application for pacritinib

    Author:
    HT Staff
    Publish date: March 27, 2017

    CTI BioPharma has withdrawn its application for marketing authorization of pacritinib (Enpaxiq) in the European Union, according to the European...

    • Read More

    News

    CHMP recommends product for hemophilia B

    Author:
    HT Staff
    Publish date: March 26, 2017

    The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for nonacog beta...

    • Read More

    News

    CHMP recommends drug for relapsed/refractory cHL

    Author:
    HT Staff
    Publish date: March 25, 2017

    The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for the anti-PD-1 therapy...

    • Read More

    News

    Most blood cancer mutations due to DNA replication errors

    Author:
    HT Staff
    Publish date: March 24, 2017

    A new study supports the idea that most cancer-driving mutations are a result of DNA replication errors, not heredity or lifestyle/environmental...

    • Read More

    News

    Preterm births more common in cancer survivors

    Author:
    HT Staff
    Publish date: March 24, 2017

    Women diagnosed with cancer during their childbearing years have an increased risk of preterm births, according to research published in JAMA...

    • Read More

    News

    ASCO reports progress, challenges in cancer care

    Author:
    HT Staff
    Publish date: March 24, 2017

    The US cancer care delivery system is undergoing changes to better meet the needs of cancer patients, but persistent hurdles threaten to slow...

    • Read More

    News

    EMA recommends orphan designation for cord blood product

    Author:
    HT Staff
    Publish date: March 24, 2017

    The European Medicines Agency’s (EMA’s) Committee for Orphan Medicinal Products has recommended that NiCord® receive orphan designation as a...

    • Read More

    News

    Lungs may play key role in blood production, doc says

    Author:
    HT Staff
    Publish date: March 23, 2017

    The lungs may play a previously unrecognized role in blood production, according to preclinical research published in Nature. Researchers...

    • Read More

    News

    CDT use and outcomes differ between sexes

    Author:
    HT Staff
    Publish date: March 23, 2017

    New research has revealed sex-based differences in utilization and outcomes of catheter-directed thrombolysis (CDT) in patients with deep vein...

    • Read More

    News

    New resource designed to help prevent CINV

    Author:
    HT Staff
    Publish date: March 23, 2017

    The Hematology/Oncology Pharmacy Association (HOPA) has announced the release of a toolkit intended to help prevent chemotherapy-induced nausea...

    • Read More

    News

    Genetically guided warfarin dosing can lower AE risk

    Author:
    HT Staff
    Publish date: March 22, 2017

    WASHINGTON, DC—Using genetic testing to guide warfarin dosing can lower the risk of combined adverse events (AEs) after elective orthopedic...

    • Read More

    Pages

    • « first
    • …
    • 68
    • 69
    • 70
    • 71
    • 72
    • 73
    • 74
    • 75
    • 76
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery